Abstract
The efficacy of ciprofloxacin and moxifloxacin against Nocardia brasiliensis was evaluated by applying 25 mg of each drug/kg subcutaneously every 8 h in BALB/c mice infected with N. brasiliensis. A statistically significant difference was observed only with moxifloxacin. A moxifloxacin-trimethoprim-sulfamethoxazole combination was as active as when each compound was used alone.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Aza Compounds / pharmacology*
-
Ciprofloxacin / pharmacology*
-
Disease Models, Animal
-
Female
-
Fluoroquinolones
-
Mice
-
Mice, Inbred BALB C
-
Microbial Sensitivity Tests
-
Moxifloxacin
-
Mycetoma / drug therapy*
-
Mycetoma / microbiology*
-
Nocardia / drug effects*
-
Nocardia / pathogenicity*
-
Quinolines / pharmacology*
Substances
-
Aza Compounds
-
Fluoroquinolones
-
Quinolines
-
Ciprofloxacin
-
Moxifloxacin